Loading
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (2 ops.)
Latest filing published 14 Oct 2026 for Fennec Pharmaceuticals INC., €13k. Read the official filing
Filing timeline
BuySaleRobert Christopher Andrade
Insider track record
Disclosed buys
7
Disclosed sells
2
Signal history
Robert Christopher Andrade: trading record in brief
This profile gathers the share dealings of Robert Christopher Andrade in Fennec Pharmaceuticals Inc. Between 1 June 2026 and 12 October 2026, the trades on record add up to 9 filings.
Both buying and selling appear: 7 purchases worth €83k, against 2 sales worth €849k. The totals exclude 5 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The record was last updated on 14 October 2026 with an open-market purchase (€13k) in Fennec Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert Christopher Andrade
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
3,846 shares@ CA$5.53Common SharesTSXSEDI:4791107
Canonical exit: 10 Jan 2027 (T+90)
1,703 sharesCommon SharesTSXSEDI:4783539
Canonical exit: 30 Dec 2026 (T+90)
1,703 sharesCommon SharesTSXSEDI:4774703
Canonical exit: 3 Dec 2026 (T+90)
21,928 shares@ CA$5.100.021% mcap8.2% of flowOptionsTSXSEDI:4770040
106,844 shares@ CA$11.790.24% mcap91.8% of flowCommon SharesTSXSEDI:4769718
1,703 sharesCommon SharesTSXSEDI:4758147
Canonical exit: 1 Nov 2026 (T+90)
1,703 sharesCommon SharesTSXSEDI:4744624
Canonical exit: 29 Sept 2026 (T+90)
1,703 sharesCommon SharesTSXSEDI:4729072
Canonical exit: 30 Aug 2026 (T+90)
8 of 8 declarations
